Skip to main content


Figure 1 | BMC Immunology

Figure 1

From: Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells

Figure 1

Impact of OVA 323-339 and OVA 323-339 MAP intervention on airway inflammation in mice. After OVA sensitization and challenge, typical airway inflammation was observed in Balb/c mice. The airway inflammation was not significantly alleviated by subcutaneous injection of 200 μg of OVA323-339 peptide monomers. However, OVA323-339MAP, containing the equivalent weight of peptides, significantly reduced peritracheal inflammatory cells infiltration and this effect was dose-dependent. Data represent one of three independent experiments.

Back to article page